Stock listing
gettex:BRM Bristol-Myers Squibb Company Aktie
German listing (gettex) of Bristol-Myers Squibb Company · home listing NYSE:BMY
Follow Bristol-Myers Squibb Company into a list and get an email when it puts out news.
Home listing price · NYSE:BMY
$61.48 USD -1.52 (-2.4%)
Close on Oct 23, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:BMY
- Day range
- $61.31 – $62.84 USDOct 23, 2026
- Volume
- 9.76M sharesOct 23, 2026
- Market cap
- $125.6B USDAt the close on Oct 23, 2026 · price × 2.04B shares outstanding
- 52-week range
- $42.52 – $68.64 USDLowest and highest trades, Oct 24, 2025 – Oct 23, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:BMY · Home | $61.48 USD | -1.52 (-2.4%) | 9,762,441 | $62.66 | $62.84 | $61.31 | $63.00 | Close on Oct 23, 2026 |
| Xetra:BRM | €55.15 EUR | -0.93 (-1.7%) | 1,384 | €55.93 | €56.21 | €54.82 | €56.08 | Close on Oct 23, 2026 |
| BMV:BMY | $1,185.00 MXN | +48.00 (+4.2%) | 86 | $1,150.00 | $1,185.00 | $1,150.00 | $1,137.00 | Close on Oct 22, 2026 |
| B3:BMYB34 | 296.57 BRL | -6.61 (-2.2%) | 150 | 296.57 | 296.57 | 296.57 | 303.18 | Close on Oct 19, 2026 |
| Frankfurt:BRM | €55.46 EUR | -0.49 (-0.9%) | — | €55.83 | €55.83 | €55.46 | €55.95 | Close on Oct 23, 2026 |
| Munich:BRM | €55.81 EUR | +1.26 (+2.3%) | — | €55.81 | €55.81 | €55.81 | €54.55 | Close on Oct 23, 2026 |
| Hamburg:BRM | €55.16 EUR | -0.83 (-1.5%) | — | €55.81 | €55.94 | €55.16 | €55.99 | Close on Oct 23, 2026 |
| Dusseldorf:BRM | €54.98 EUR | -0.93 (-1.7%) | — | €55.77 | €55.78 | €54.98 | €55.91 | Close on Oct 23, 2026 |
Daily closes
Last 3 months, Jul 23, 2026 – Oct 23, 2026 · NYSE:BMY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $61.48 | -1.52 | -2.4% | $62.66 | $62.84 | $61.31 | 9,762,441 | |
| $63.00 | +1.88 | +3.1% | $61.46 | $63.59 | $61.04 | 15,169,240 | |
| $61.12 | -0.56 | -0.9% | $61.50 | $61.81 | $60.69 | 9,016,433 | |
| $61.68 | +2.85 | +4.8% | $59.93 | $61.82 | $59.83 | 11,908,560 | |
| $58.83 | -0.92 | -1.5% | $59.40 | $59.87 | $58.44 | 11,551,820 | |
| $59.75 | -0.82 | -1.4% | $61.10 | $61.43 | $59.54 | 13,770,800 | |
| $60.57 | +1.29 | +2.2% | $60.67 | $62.25 | $60.39 | 13,752,200 | |
| $59.28 | +2.61 | +4.6% | $56.81 | $59.39 | $56.58 | 14,045,600 | |
| $56.67 | -0.91 | -1.6% | $57.78 | $58.02 | $56.15 | 16,958,100 | |
| $57.58 | -1.54 | -2.6% | $60.11 | $60.68 | $56.72 | 22,564,700 | |
| $59.12 | -0.46 | -0.8% | $58.88 | $59.79 | $58.74 | 9,252,700 | |
| $59.58 | -0.12 | -0.2% | $59.10 | $59.94 | $58.73 | 13,070,600 | |
| $59.70 | +0.11 | +0.2% | $59.45 | $60.10 | $59.01 | 11,091,200 | |
| $59.59 | +0.78 | +1.3% | $58.94 | $59.60 | $58.64 | 9,885,400 | |
| $58.81 | -2.34 | -3.8% | $59.89 | $60.15 | $58.33 | 19,237,900 | |
| $61.15 | -0.31 | -0.5% | $60.66 | $61.24 | $60.24 | 9,933,500 | |
| $61.46 | -0.94 | -1.5% | $62.20 | $62.61 | $61.25 | 10,768,200 | |
| $62.40 | -0.46 | -0.7% | $63.28 | $64.13 | $62.40 | 15,867,300 | |
| $62.86 | -1.02 | -1.6% | $63.58 | $63.89 | $61.95 | 15,835,700 | |
| $63.88 | +1.02 | +1.6% | $62.77 | $63.93 | $62.30 | 14,018,700 | |
| $62.86 | +1.36 | +2.2% | $61.75 | $62.91 | $61.40 | 10,672,800 | |
| $61.50 | +0.35 | +0.6% | $61.40 | $61.59 | $60.60 | 14,901,900 | |
| $61.15 | -1.10 | -1.8% | $62.31 | $62.65 | $61.08 | 15,842,800 | |
| $62.25 | -0.37 | -0.6% | $62.73 | $63.08 | $62.03 | 15,235,100 | |
| $62.62 | -0.44 | -0.7% | $63.09 | $63.40 | $62.62 | 6,837,900 | |
| $63.06 | +0.22 | +0.4% | $62.71 | $63.07 | $62.19 | 36,849,600 | |
| $62.84 | -0.76 | -1.2% | $64.08 | $64.35 | $62.52 | 12,211,300 | |
| $63.60 | -0.13 | -0.2% | $64.07 | $64.39 | $63.22 | 9,448,900 | |
| $63.73 | -0.37 | -0.6% | $63.94 | $64.13 | $63.15 | 9,995,200 | |
| $64.10 | +0.46 | +0.7% | $64.59 | $65.29 | $63.91 | 6,903,300 | |
| $63.64 | -0.11 | -0.2% | $64.15 | $64.20 | $63.27 | 7,054,400 | |
| $63.75 | -0.66 | -1.0% | $64.92 | $64.92 | $63.73 | 6,495,100 | |
| $64.41 | -0.28 | -0.4% | $64.57 | $65.05 | $64.26 | 6,573,400 | |
| $64.69 | -2.13 | -3.2% | $65.66 | $65.89 | $64.40 | 9,522,900 | |
| $66.82 | -1.27 | -1.9% | $67.24 | $67.72 | $66.58 | 4,825,300 | |
| $68.09 | +0.43 | +0.6% | $68.08 | $68.24 | $66.62 | 6,224,000 | |
| $67.66 | +0.74 | +1.1% | $66.82 | $67.73 | $66.75 | 7,823,700 | |
| $66.92 | +0.11 | +0.2% | $67.58 | $68.04 | $66.65 | 6,933,300 | |
| $66.81 | +0.23 | +0.3% | $66.25 | $67.20 | $65.91 | 12,681,800 | |
| $66.58 | -0.37 | -0.6% | $66.77 | $66.84 | $66.19 | 5,542,900 | |
| $66.95 | -0.62 | -0.9% | $66.59 | $67.47 | $66.20 | 4,667,100 | |
| $67.57 | -0.35 | -0.5% | $67.74 | $68.00 | $67.32 | 7,511,200 | |
| $67.92 | +0.64 | +1.0% | $66.42 | $68.05 | $66.42 | 7,911,500 | |
| $67.28 | +0.27 | +0.4% | $67.41 | $67.41 | $66.45 | 6,812,100 | |
| $67.01 | +1.54 | +2.4% | $65.79 | $67.55 | $65.13 | 6,841,300 | |
| $65.47 | -2.14 | -3.2% | $67.23 | $67.54 | $65.45 | 9,489,600 | |
| $67.61 | +1.56 | +2.4% | $66.80 | $68.64 | $66.61 | 13,889,200 | |
| $66.05 | +1.42 | +2.2% | $65.30 | $66.38 | $65.00 | 9,413,800 | |
| $64.63 | +0.80 | +1.3% | $63.60 | $64.74 | $63.36 | 7,288,800 | |
| $63.83 | -0.82 | -1.3% | $64.13 | $64.33 | $63.35 | 7,529,800 | |
| $64.65 | +0.95 | +1.5% | $64.05 | $65.02 | $63.91 | 10,526,100 | |
| $63.70 | +0.09 | +0.1% | $63.49 | $64.00 | $63.00 | 7,509,600 | |
| $63.61 | -1.23 | -1.9% | $64.56 | $65.02 | $63.54 | 9,366,700 | |
| $64.84 | +0.12 | +0.2% | $64.33 | $65.25 | $64.12 | 9,753,300 | |
| $64.72 | +0.57 | +0.9% | $64.24 | $64.73 | $63.79 | 7,212,900 | |
| $64.15 | +0.52 | +0.8% | $64.90 | $64.94 | $63.20 | 9,553,600 | |
| $63.63 | -2.26 | -3.4% | $64.81 | $65.41 | $63.26 | 14,117,100 | |
| $65.89 | +0.42 | +0.6% | $64.89 | $66.31 | $63.87 | 23,292,800 | |
| $65.47 | +0.16 | +0.2% | $66.12 | $68.10 | $64.14 | 32,970,900 | |
| $65.31 | +0.45 | +0.7% | $65.00 | $65.66 | $63.53 | 14,580,300 | |
| $64.86 | +1.76 | +2.8% | $62.69 | $65.56 | $62.23 | 18,031,400 | |
| $63.10 | -0.50 | -0.8% | $63.87 | $63.91 | $63.10 | 10,606,600 | |
| $63.60 | +1.04 | +1.7% | $63.65 | $64.97 | $63.20 | 15,141,700 | |
| $62.56 | +0.47 | +0.8% | $62.40 | $63.44 | $62.22 | 10,317,000 | |
| $62.09 | +0.58 | +0.9% | $61.94 | $62.82 | $61.60 | 12,071,700 | |
| $61.51 | +0.75 | +1.2% | $60.74 | $62.05 | $60.45 | 7,621,800 |
- Ticker
- gettex:BRM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 23, 2026
Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MSToronto 2026
Latest earnings call · Jul 30, 2026
Bristol-Myers Squibb (NYSE:BMY) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Jul 30, 2026
Q2 2026 Earnings Presentation
Earnings · 57 slides
Calls
Upcoming
Bristol-Myers Squibb (NYSE:BMY) Q3 2026 Earnings Call
Thu, Oct 29, 2026 · 8:00 AM ET
Register
Replays
Bristol-Myers Squibb (NYSE:BMY) Q2 2026 Earnings Call
Thu, Jul 30, 2026 · 8:15 AM ET
Watch TranscriptBristol-Myers Squibb (NYSE:BMY) Q1 2026 Earnings Call
Thu, Apr 30, 2026 · 8:00 AM ET
Watch TranscriptBristol-Myers Squibb (NYSE:BMY) Q4 2025 Earnings Call
Thu, Feb 05, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Bristol Myers Squibb Presents Results from Phase 1 Breakfree-2 Study of Zolacabtagene Autoleucel (BMS-986353) in Patients with Highly Active Relapsing and Progressive Forms of Multiple Sclerosis at MSToronto 2026
Oct 23, 2026
Closed $61.48 (-2.4%) on Oct 23, 2026
Izalontamab Brengitecan (Iza-Bren) Reduced Risk of Disease Progression or Death by 59% versus Chemotherapy in Patients with Advanced HR+/HER2- Breast Cancer in Phase 3 PANKU-Breast01 Study
Oct 23, 2026
Closed $61.48 (-2.4%) on Oct 23, 2026
Bristol Myers Squibb to Showcase Next-Generation Cancer Modalities and Leadership Across Solid Tumors at ESMO 2026
Oct 19, 2026
Closed $58.83 (-1.5%) on Oct 19, 2026
Bristol Myers Squibb Announces Positive Topline Results from the Interim Analysis of Phase 3 ACTION-1 for RYZ101, RayzeBio’s Radiopharmaceutical Therapy, in Patients with GEP-NETs
Oct 12, 2026
Closed $57.58 (-2.6%) on Oct 12, 2026
Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary Endpoint
Oct 12, 2026
Closed $57.58 (-2.6%) on Oct 12, 2026
On the 12th Edition of Global Patient Week Bristol Myers Squibb and Saudi Schizophrenia Association 'Ehtiwaa' Collaborate to Support People Living with Schizophrenia Through the 'Small Wins' Initiative
Oct 12, 2026
Closed $57.58 (-2.6%) on Oct 12, 2026
Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-Free Survival vs. Standard of Care in Relapsed and Refractory Multiple Myeloma in Phase 3...
Oct 8, 2026
Closed $59.58 (-0.2%) on Oct 8, 2026
Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement
Oct 5, 2026
Closed $58.81 (-3.8%) on Oct 5, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 57 slides · Jul 30, 2026
Q2 2026 Earnings Presentation
Earnings · 16 slides · Jul 30, 2026
Q1 2026 Earnings Presentation
Earnings · 58 slides · Apr 30, 2026
Q1 2026 Earnings Presentation
Earnings · 16 slides · Apr 30, 2026
Bristol-Myers Squibb Company on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 109 in the last 12 months · 155 in all · newest Oct 23, 2026 · oldest 2025
- Calls
- 31 calls with a replay · 31 with a transcript · latest Jul 30, 2026
- Decks
- 64 decks · latest Jul 30, 2026
Where Bristol-Myers Squibb Company is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:BMY · Home listing | NYSE | United States | USD |
| BCBA:BMY | BCBA | Argentina | ARS |
| gettex:BRM · This page | gettex | Germany | EUR |
| Tradegate:BRM | Tradegate | Germany | EUR |
| Xetra:BRM | Xetra | Germany | EUR |
| BMV:BMY | BMV | Mexico | MXN |
| LS Exchange:850501 | LS Exchange | Germany | EUR |
| Lang & Schwarz:850501 | Lang & Schwarz | Germany | EUR |
| Stuttgart:BRM | Stuttgart | Germany | EUR |
| BOATS:BMY | BOATS | United States | USD |
| B3:BMYB34 | B3 | Brazil | BRL |
| Milan:1BMY | Milan | Italy | EUR |
| Frankfurt:BRM | Frankfurt | Germany | EUR |
| SIX Swiss:BMY | SIX Swiss | Switzerland | CHF |
| BCBA:BMYD | BCBA | Argentina | USD |
| BIVA:BMY | BIVA | Mexico | MXN |
| SIX Swiss:BMY.USD | SIX Swiss | Switzerland | USD |
| LSIN:0R1F | LSIN | United Kingdom | USD |
| Munich:BRM | Munich | Germany | EUR |
| EUROTLX:4BMY | EUROTLX | Italy | EUR |
| Hamburg:BRM | Hamburg | Germany | EUR |
| Hanover:BRM | Hanover | Germany | EUR |
| BVL:BMYUS | BVL | Peru | PEN |
| BCBA:BMYB | BCBA | Argentina | ARS |
| Dusseldorf:BRM | Dusseldorf | Germany | EUR |
| VIE:BMYS | Vienna | Austria | EUR |
| Aquis:BRMD | Aquis | United Kingdom | EUR |
| Aquis:BRMD | Aquis | United Kingdom | EUR |
| BX Swiss:BRM | BX Swiss | Switzerland | CHF |
| BCBA:BMYC | BCBA | Argentina | USD |
| Turquoise:BMYN | Turquoise | United Kingdom | USD |
| BCBA:BMY.CI | BCBA | Argentina | ARS |
Log in to ask 6ix AI your own questions about Bristol-Myers Squibb Company.